论文部分内容阅读
目的观察活血素(二氢麦角隐亭)口服液治疗前庭性眩晕患者的疗效及不良反应。方法对318例16～74岁的前庭性眩晕患者分为活血素口服液(A组),利多卡因静脉滴注(B组),两药联合应用(C组)。3组进行治疗,并予以疗效观察。结果治疗效果提示,A组的总有效率89.1%,B组的总有效率为68.9%,C组的总有效率为92.2%。结论临床观察表明,活血素口服液治疗前庭性眩晕较之利多卡因静脉滴注有统计学差异。两药联用可增强疗效,并可减少活血素治疗的不良反应。
Objective To observe the curative effect and adverse reactions of hematin (dihydroergocryptine) oral solution in patients with vestibular vertigo. Methods 318 patients with vestibular vertigo between 16 and 74 years old were divided into two groups: group A, group L, group C, group C, and group C. 3 groups for treatment, and to observe the efficacy. Results The curative effect indicated that the total effective rate of group A was 89.1%, the total effective rate of group B was 68.9% and the total effective rate of group C was 92.2%. Conclusions Clinical observation shows that the treatment of vestibular dizziness with huoxuetong oral solution has statistical difference compared with intravenous injection of lidocaine. Combination of two drugs can enhance the curative effect, and can reduce the adverse reaction of the treatment of hematin.